For cancer cells, sarcopenia may lead to energy supply insufficiency and limit the availability of nutrients, enabling cancer cells to evade immune responses and weaken the effectiveness of PD-1 inhibitors. This evidence concerns the gene PDCD1 and sarcopenia.